Document is current

Article History

Received: 1 September 2020

Accepted: 14 October 2020

First Online: 1 November 2020

Compliance with ethical standards

:

: Dr. Mark received advisory fees from BMS, MSD, AstraZeneca, Roche, and Takeda; and received institutional research grants from AstraZeneca. Dr. Froesch received advisory fees from Roche, Takeda, Pfizer, and Boehringer Ingelheim. Dr. Addeo received compensation from Bristol-Myers Squibb, AstraZeneca, Merck Sharpe & Dohme, Takeda, Pfizer, Roche, and Boehringer Ingelheim for participating in advisory boards. Dr. Früh received advisory fees (paid to institution) from Bristol-Myers Squibb, Merck Sharpe & Dohme, AstraZeneca, Boehringer Ingelheim, Roche, and Takeda; and received institutional research grants from Bristol-Myers Squibb and AstraZeneca. Dr. Rothschild received honoraria (paid to institution) from Roche and AstraZeneca; and received consultancy/advisory fees (paid to institution) from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Pfizer, Eisai, and Eli Lilly. Dr. Pless received compensation from Abbvie, AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Eisai, Merck Sharpe & Dohme, Novartis, Pfizer, Roche, Takeda, and Merck for participating in advisory boards; received travel grants from AstraZeneca, Bristol-Myers Squibb, Boehringer Ingelheim, Roche, Takeda, and Vifor; and received speaking fees from Janssen. Dr. Weindler received honoraria (paid to institution) from Merck; and received travel grants (paid to institution) from Roche. The remaining authors declare no conflict of interest.